Guangdong Marubi Biotechnology Stock Revenue
| 603983 Stock | 31.00 1.85 6.35% |
Guangdong Marubi Biotechnology fundamentals help investors to digest information that contributes to Guangdong Marubi's financial success or failures. It also enables traders to predict the movement of Guangdong Stock. The fundamental analysis module provides a way to measure Guangdong Marubi's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Guangdong Marubi stock.
| Last Reported | Projected for Next Year | ||
| Total Revenue | 2.2 B | 1.8 B |
Guangdong | Revenue |
Guangdong Marubi Biotechnology Company Revenue Analysis
Guangdong Marubi's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Guangdong Marubi Revenue | 2.23 B |
Most of Guangdong Marubi's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Guangdong Marubi Biotechnology is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Historical and Projected quarterly revenue of Guangdong
Projected quarterly revenue analysis of Guangdong Marubi Bio provides investors and stakeholders with an insight into the company's performance and growth prospects. When actual revenues of Guangdong Marubi match or exceed analyst estimates, it positively influences investor confidence and market perception, often leading to a rise in Guangdong Marubi's stock price.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
Guangdong Total Revenue
Total Revenue |
|
Based on the latest financial disclosure, Guangdong Marubi Biotechnology reported 2.23 B of revenue. This is 85.02% lower than that of the Personal Care Products sector and 80.85% lower than that of the Consumer Staples industry. The revenue for all China stocks is 76.41% higher than that of the company.
Guangdong Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Guangdong Marubi's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Guangdong Marubi could also be used in its relative valuation, which is a method of valuing Guangdong Marubi by comparing valuation metrics of similar companies.Guangdong Marubi is currently under evaluation in revenue category among its peers.
Guangdong Fundamentals
| Return On Equity | 0.1 | ||||
| Return On Asset | 0.039 | ||||
| Profit Margin | 0.12 % | ||||
| Operating Margin | 0.10 % | ||||
| Current Valuation | 10.83 B | ||||
| Shares Outstanding | 401 M | ||||
| Shares Owned By Insiders | 80.79 % | ||||
| Shares Owned By Institutions | 7.46 % | ||||
| Price To Book | 3.68 X | ||||
| Price To Sales | 4.56 X | ||||
| Revenue | 2.23 B | ||||
| Gross Profit | 1.14 B | ||||
| EBITDA | 277.35 M | ||||
| Net Income | 259.42 M | ||||
| Total Debt | 100.07 M | ||||
| Book Value Per Share | 8.42 X | ||||
| Cash Flow From Operations | 338.02 M | ||||
| Earnings Per Share | 0.82 X | ||||
| Target Price | 31.19 | ||||
| Number Of Employees | 1.1 K | ||||
| Beta | 0.21 | ||||
| Market Capitalization | 12.04 B | ||||
| Total Asset | 4.45 B | ||||
| Retained Earnings | 1.99 B | ||||
| Working Capital | 1.52 B | ||||
| Net Asset | 4.45 B | ||||
| Last Dividend Paid | 0.52 |
About Guangdong Marubi Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Guangdong Marubi Biotechnology's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Guangdong Marubi using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Guangdong Marubi Biotechnology based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Guangdong Stock
Guangdong Marubi financial ratios help investors to determine whether Guangdong Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Guangdong with respect to the benefits of owning Guangdong Marubi security.